Sarah Neagle

Biological Asset Management Scientist
GlaxoSmithKline


11:40 AM Addressing the Challenges of Reconciling and Transferring Biological Asset Inventories to Automated Systems

  • Hear about GSK’s massive changes over the past few years in the ways they store biological assets as an enterprise
  • Decipher the challenges of consolidating (from multiple GSK locations), reconciling (determining current and future need of said asset) and automating (robotic freezers that house and pull these assets in an automated fashion) a variety of biological asset
inventories (e.g. cell lines, DNA plasmids, viruses, bacterial strains, histological slides, proteins etc.)